AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 104 filers reported holding AMAG PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $5,190,000 | +69.9% | 402,882 | +100.4% | 0.06% | -19.7% |
| Q4 2018 | $3,054,000 | +16.7% | 201,048 | +167.3% | 0.08% | +65.2% |
| Q4 2016 | $2,617,000 | -42.1% | 75,201 | -59.2% | 0.05% | -47.1% |
| Q3 2016 | $4,518,000 | +30.8% | 184,326 | +24.9% | 0.09% | +24.3% |
| Q1 2016 | $3,453,000 | -23.5% | 147,551 | -1.3% | 0.07% | -23.1% |
| Q4 2015 | $4,514,000 | +93.2% | 149,531 | +154.3% | 0.09% | +89.6% |
| Q3 2015 | $2,336,000 | +65.1% | 58,795 | +127.1% | 0.05% | +92.0% |
| Q1 2015 | $1,415,000 | +350.6% | 25,894 | +251.7% | 0.02% | +316.7% |
| Q4 2014 | $314,000 | -55.3% | 7,363 | -66.6% | 0.01% | -57.1% |
| Q3 2014 | $703,000 | -89.7% | 22,041 | -92.2% | 0.01% | -89.0% |
| Q4 2013 | $6,852,000 | +23.7% | 282,215 | +9.4% | 0.13% | +18.7% |
| Q3 2013 | $5,538,000 | -8.2% | 257,880 | -4.9% | 0.11% | -13.0% |
| Q2 2013 | $6,030,000 | – | 271,028 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 4,390,000 | $33,584,000 | 1.92% |
| Bleichroeder LP | 1,299,994 | $9,945,000 | 1.76% |
| ARMISTICE CAPITAL, LLC | 4,120,000 | $31,518,000 | 1.38% |
| Palo Alto Investors LP | 2,959,587 | $22,641,000 | 1.36% |
| Permanens Capital L.P. | 359,461 | $2,750,000 | 1.04% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 31,607 | $242,000 | 0.19% |
| BOOTHBAY FUND MANAGEMENT, LLC | 348,000 | $2,662,000 | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 795,611 | $6,086,000 | 0.07% |
| Teza Capital Management LLC | 23,269 | $178,000 | 0.04% |
| Livforsakringsbolaget Skandia, Omsesidigt | 38,800 | $297,000 | 0.03% |